PowerTOST: CVfromCI [Study As­sess­ment]

posted by Rosy – Mexico, 2019-02-20 15:25 (580 d 18:31 ago) – Posting: # 19939
Views: 6,118

(edited by Rosy on 2019-02-20 15:37)

»              Not interested in other members’ opinions?

I'm sorry if I looked rude, I was just trying to follow the thread of the publication ... of course, I'm interested in any opinion. My deepest apologies to everyone.

» Parallel‽

I had a miscomprehension of the statistical analysis, i read again and they used an ANOVA included the following factors: sequence (SEQ), subject nested within sequence (SUBJECT [SEQ]), period (PHASE), and treatment (TREAT). I though that they maked a paired comparation, one at time.

But in this case: https://accp1.onlinelibrary.wiley.com/doi/abs/10.1177/009127009903901108?sid=nlm%3Apubmed

The study had an open-label, single-dose, three-way crossover design. Subjects were randomly assigned to receive one of three treatments per period

Design: 3x2 N= 17

A vs B ----> IC (84.9-106)
A vs C ----> IC (169-211)
B vs C ----> IC (178-222)

How to calculate %CV Intra-individual???

100*CVfromCI(lower=0.849, upper=1.06, n=17, design='2x2x3', alpha=0.05)

it's that correct???

Complete thread:

Activity
 Admin contact
21,071 posts in 4,393 threads, 1,466 registered users;
online 9 (1 registered, 8 guests [including 1 identified bots]).
Forum time: Wednesday 10:56 CEST (Europe/Vienna)

The important thing in science is not so much to obtain new facts
as to discover new ways of thinking about them.    William Henry Bragg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5